Drug profile · INN
cariprazine
REAGILA
cariprazine (REAGILA) is a dopamine d3 receptor modulator.
EMA: approved TGA: approved NMPA: clinical trials Nervous system (N05) N05AX15
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — cariprazine
- Class
- Nervous system (N05)
- Route
- —
- Patents
- 0
- Programs
- 5
- Data quality
- 0.83
Quick answer
cariprazine (REAGILA) is a dopamine d3 receptor modulator.
Key facts
INN cariprazine
Brand REAGILA
Mechanism Dopamine D3 receptor modulator
Therapeutic class Nervous system (N05)
ATC code N05AX15
Mechanism of action
Dopamine D3 receptor modulator
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is cariprazine?
cariprazine (REAGILA) is a dopamine d3 receptor modulator.
What is the brand name for cariprazine?
REAGILA is a marketed brand name for cariprazine. Check FDA Drugs@FDA for the current US label holder and prescribing information.